Medications

India licenses generic copy of patented Bayer drug

(AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.

Other

Pharma lobby blasts 'stupid' pandemic patent plans

Stripping patent protection from COVID-19 treatments is a "mind-bogglingly stupid" idea, the head of a leading pharmaceutical lobby said Wednesday, warning that the move would put industry innovation at risk.

Vaccination

What's at stake in COVID-19 jab patent waiver row

Over a year into global COVID-19 vaccination efforts the question of whether jab formulas ought to be freely available is still unresolved—and undersupplied countries are turning to workarounds.

Vaccination

Merkel urges US to export COVID vaccines

German Chancellor Angela Merkel on Saturday urged the United States to export coronavirus vaccines made on its soil, as she rejected a patent waiver call from Washington for the jabs.

Vaccination

World mulls next step as US backs IP waiver on vaccines

Activists cheered, Big Pharma complained and government leaders assessed next steps on Thursday after the Biden administration's blockbuster move to support an easing of patent and other protections on COVID-19 vaccines that ...

Vaccination

US backs plan to waive COVID-19 vaccine patents

US President Joe Biden's administration on Wednesday announced support for a global waiver on patent protections for COVID-19 vaccines, offering hope to poor nations that have struggled to access the life-saving doses.

Vaccination

WTO mulling intellectual property waivers for vaccines

Ambassadors from World Trade Organization countries on Wednesday resumed discussions on trade rules protecting the technological know-how behind COVID-19 vaccines amid growing pressure on rich nations to relax them—as a ...

page 2 from 3